One of the areas I wanted to highlight is to thank the health committee for its work and the research it has been doing in a number of areas. I'm looking forward to reviewing the recommendations coming from this committee around health human resources, as an example. That is important work that I need to look at in terms of the advice coming from the health committee.
The other area is related to the sodium reduction initiative. This summer, the working group will be releasing its report, and I want to thank the committee for the work and research you did around sodium, as an example.
I particularly want to thank the committee members for the important work they did last night in the debate around MS. This is a very important initiative that we've undertaken with CIHR and in partnership with the MS Society.
At the same time, every jurisdiction is looking to Health Canada for the research they need to deliver their health care. I'm proud to say that CIHR is taking leadership in mobilizing the research community within Canada that would specifically target research in this particular area, in partnership with the MS Society. We've been moving very quickly on that, and I want to thank the committee members for their contributions last evening.
At the same time, I will state that every jurisdiction across Canada that delivers health care is looking for this research. Through the leadership of Dr. Beaudet, we'll be able to mobilize the research team not just within Canada but within the international community.
I wanted to share that information with you, because I think everyone recognizes the importance of the work in this area, as we discussed last night.
Thank you.